The market is anticipated to rise favorably as the prevalence of cardiovascular system disorders, chronic pain diseases, and related co-morbidities increases globally. The World Health Organization (WHO) estimates that around 17 million people die each year from cardiovascular illnesses. The most prevalent kind of cardiac arrhythmia, atrial fibrillation, affects between 2.7 and 6.1 million people in the United States, according to the Centers for Disease Control and Prevention (CDC).
The global active Implantable Medical Devices Market was valued at US$ 16,721.2 million in 2016 and is expected to witness a robust CAGR of 5.4% over the forecast period (2017–2025).
Major Players in the Implantable Medical Devices Industry:
1. Cochlear Limited
Cochlear Limited founded in 1983 and its headquarters Sydney, Australia. The company operates in 100 countries.
2. Boston Scientific Corporation
Boston Scientific Corporationfounded in 1979, and its Headquarters located in Marlborough, Massachusetts, United States. The company operates in 100 nations.
